|
ZNF217 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.85750000047946E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.203700E-04 |
| Normal-vs-Stage2 |
3.581900E-02 |
| Normal-vs-Stage3 |
2.694300E-02 |
| Normal-vs-Stage4 |
1.309420E-01 |
| Stage1-vs-Stage2 |
5.049800E-01 |
| Stage1-vs-Stage3 |
3.012800E-01 |
| Stage1-vs-Stage4 |
8.106600E-01 |
| Stage2-vs-Stage3 |
6.562800E-01 |
| Stage2-vs-Stage4 |
5.470200E-01 |
| Stage3-vs-Stage4 |
2.747200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.31589999996518E-06 |
| Normal-vs-AfricanAmerican |
7.717800E-03 |
| Normal-vs-Asian |
1.288200E-01 |
| Caucasian-vs-AfricanAmerican |
2.694400E-01 |
| Caucasian-vs-Asian |
2.081000E-01 |
| AfricanAmerican-vs-Asian |
8.012000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.34470000000098E-05 |
| Normal-vs-Female |
2.36919999999641E-05 |
| Male-vs-Female |
2.364000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.903000E-03 |
| Normal-vs-Extreme_Weight |
7.964600E-03 |
| Normal-vs-Obese |
1.207720E-04 |
| Normal-vs-Extreme_Obese |
9.684000E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.182200E-01 |
| Normal_Weight-vs-Obese |
6.653700E-02 |
| Normal_Weight-vs-Extreme_Obese |
1.209970E-01 |
| Extreme_Weight-vs-Obese |
2.226200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.354400E-01 |
| Obese-vs-Extreme_Obese |
4.164800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.222100E-02 |
| Normal-vs-Age(41-60Yrs) |
1.00199999963912E-07 |
| Normal-vs-Age(61-80Yrs) |
1.576320E-03 |
| Normal-vs-Age(81-100Yrs) |
5.505000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.629640E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.985800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.733550E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.756380E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.87420000000005E-05 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.541400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.00370000042116E-07 |
| Normal-VS-Type2 PRCC |
4.788200E-01 |
| Normal-VS-KIRP CIMP |
3.043700E-02 |
| Normal-VS-Unclassified PRCC |
8.610000E-04 |
| Type1 PRCC-VS-Type2 PRCC |
7.99250000000917E-05 |
| Type1 PRCC-VS-KIRP CIMP |
8.532200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.537000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.574000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.599400E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.146040E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.902360E-01 |
| Normal-vs-N1 |
1.413650E-02 |
| Normal-vs-N2 |
5.448600E-01 |
| N0-vs-N1 |
3.497500E-02 |
| N0-vs-N2 |
6.410000E-01 |
| N1-vs-N2 |
4.661000E-01 |
|
|
